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GABA

:   *γ*‐aminobutyric acid

MPP

:   membrane‐permeable peptides

SPSS

:   statistical package for the social science

TFA

:   Trifluoroacetic acid

Introduction {#prp2334-sec-0001}
============

The arginine‐rich membrane‐permeable peptides (MPP) such as the undecapeptides TAT (YGRKKRRQRRR) and CTP (YGRRARRRRRR) have been widely used in many laboratories for carrying various kinds of exogenous bio‐molecules including peptides, proteins, nucleotides and nucleic acids to penetrate across different kinds of bio‐membranes in vitro and in vivo. However, people always concentrate their mind on the efficacy and the mechanism of permeation of the conjugates, but overlook the toxicity of the membrane‐permeable peptide itself. Once we injected intravenously not very large amounts of *γ*‐aminobutyric acid ‐TAT (GABA‐TAT) to the mice, to our great surprise, the mice died within seconds with seizure. Thus in this paper, the toxicity of MPPs *per se* was attentively studied.

Materials and Methods {#prp2334-sec-0002}
=====================

Animals {#prp2334-sec-0003}
-------

A total of 390 mice (Kunming species, 22 ± 2 g, sex matched), were provided by the Experimental animal center of Academy of military medical sciences, China. The health condition of the mice was examined to confirm their suitability for use in the study. The animal rooms were monitored and maintained under a 12 h light‐dark cycle with temperature ranging from 20 to 25°C and a relative humidity of 40--60%. All the mice were allowed to acclimate to the laboratory environment for 2 days, housed by sex in groups of five per cage, provided with standard commercial diet and drinking water ad libitum. All the animal procedures performed in this study were reviewed and approved by the Animal Experimental Welfare and Ethical Inspection Committee of the Chinese Center for Disease Control and Prevention (Approval number IACUC\#15‐026).

Reagents {#prp2334-sec-0004}
--------

The synthetic peptides TAT (YGRKKRRQRRR), CTP (YGRRARRRRRR), R11 (RRRRRRRRRRR), TD (ACSSSPSKHCG), and their GABA‐conjugates were synthetized by SBS Genetech Co, Ltd. The peptide molecular weights were confirmed by mass spectrometry, 98% in purity. The lyophilized peptides were prepared and diluted in 0.9% NaCl before use.

*γ*‐aminobutyric acid (GABA) was provided by Beijing Gleckes Bio‐engineering Technology Co. Ltd. with a purity of 99%.

TAT‐choline acetyltransferase (TAT‐ChAT): The recombinant prokaryotic plasmid of pET15‐TAT‐ChAT was constructed to express the TAT‐ChAT fusion protein in *Escherichia coli BL21* based on previous works (Fu et al. [2004](#prp2334-bib-0002){ref-type="ref"}, [2005](#prp2334-bib-0003){ref-type="ref"}). The purified TAT‐ChAT fusion protein (98% in purity) could effectively ameliorate the dementia symptom of the aged mice and the APP/PS1‐TgN transgenic mice in our other experiments. Lyophilized TAT‐ChAT was stored at −20°C, and dissolved in 0.9% saline solution before use.

Trifluoroacetic acid (TFA) was purchased from ACROS Organics (Belgian), extra pure with a purity of 99%. Formulated solutions (0.1%,0.5%,1%,2%,5%) were diluted with sterilized deionized water.

Experimental design {#prp2334-sec-0005}
-------------------

Firstly, a preliminary sequential toxicity testing was carried to find out the scope of the dosage. Then four dosages within this range were properly selected to carry on the LD~50~ estimation. The LD~50~ was calculated avoid the all or none survival groups of mice.

 {#prp2334-sec-0006}

### Experimental procedures {#prp2334-sec-0007}

Five males and five females per group were stratified by weight and assigned randomly. The control mice and those in groups 1, 2, 3, 4 were intravenously injected with different doses of MPPs or MPP‐conjugates. The general behavior and signs of toxicity were monitored for 3 h after administration, and carried on once a day up to 14 days. The surviving mice were euthanized while those died from the poisoning were necropsied.

Statistical analysis {#prp2334-sec-0008}
--------------------

All the data are expressed as the means ± standard deviation (SD), and comparisons among the different groups were performed using an analysis of variance (ANOVA). The IBM statistical package for the social science (SPSS) statistics 20 software was used for all the analysis. The significance level was set at 5 and 1% (*P *\<* *0.05 and *P *\<* *0.01). The LD~50~ value was determined according to the Bliss method (Badisa et al. [2008](#prp2334-bib-0001){ref-type="ref"}).

Results {#prp2334-sec-0009}
=======

LD~50~ of MPPs and their GABA conjugates {#prp2334-sec-0010}
----------------------------------------

Firstly, we found that TAT or CTP injected *via* the tail vein were highly toxic to the mice (Table [1](#prp2334-tbl-0001){ref-type="table-wrap"}). The low LD~50~ values of TAT (27.244 mg kg^−1^) and CTP (21.345 mg kg^−1^) indicate that they all fall within the range of highly toxic chemicals (Table [2](#prp2334-tbl-0002){ref-type="table-wrap"}). GABA is not toxic at all even at dose as high as 8000 mg kg^−1^. However, when TAT and CTP were, respectively, conjugated with GABA and intravenously injected to mice, the toxicity of the conjugates became even higher than that of TAT or CTP alone (Table [3](#prp2334-tbl-0003){ref-type="table-wrap"}). The mice immediately jumped up, kicked the hind‐limbs, and manifested bug‐eyes and abdominal respiration. All the mice were difficult to turn‐over the body and died within one minute.

###### 

Weight ratios of the membrane‐permeable peptides in their conjugates (mice,iv injection. aa denotes the amino acid residue)

                Dosage(mg kg^−1^)   Survival rate (%)   Molecular weight (Dalton)   Weight of MPP in conjugates (%)   References
  ------------- ------------------- ------------------- --------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------------------
  GABA          8000                100                 103                         0                                 
  TD (11aa)     140                 100                 1065                        100                               
  TAT(11aa)     27                  50                  1560                        100                               
  CTP(11aa)     21                  50                  1558                        100                               
  R11(11aa)     16.5                50                  1735                        100                               
  GABA --TD     100                 100                 1149                        92.7                              
  GABA --TAT    19                  50                  1645                        94.8                              
  GABA --CTP    13                  50                  1644                        94.8                              
  TAT --ChAT    339                 50                  70000                       2.2                               
  TAT --hEGF    0.1                 100                 7000                        22.3                              Zhao et al. ([2011a](#prp2334-bib-0009){ref-type="ref"})
  TAT --BDNF    5                   100                 14400                       10.8                              Zhou et al. ([2008](#prp2334-bib-0011){ref-type="ref"});
  TAT --tCNTF   1                   100                 21664                       7.2                               Qu et al. ([2008](#prp2334-bib-0005){ref-type="ref"})
  TAT ‐P53      5                   100                 54000                       2.9                               Zhao et al. ([2009](#prp2334-bib-0008){ref-type="ref"}); Zhao et al. ([2011b](#prp2334-bib-0010){ref-type="ref"})
  TAT ‐TH       8                   100                 61000                       2.6                               Wu et al. ([2006](#prp2334-bib-0007){ref-type="ref"}); Fu et al. ([2006](#prp2334-bib-0004){ref-type="ref"});
  TAT --ChAT    4                   100                 70000                       2.2                               Fu et al. ([2004](#prp2334-bib-0002){ref-type="ref"}, [2005](#prp2334-bib-0003){ref-type="ref"})

MPP, membrane‐permeable peptides; GABA, *γ*‐aminobutyric acid.

John Wiley & Sons, Ltd

###### 

Mortality of mice in acute toxicity study (*n* = 10)

  MPPs            LD50 (mg kg^−1^)   Groups             Control group   1      2      3      4
  --------------- ------------------ ------------------ --------------- ------ ------ ------ ----
  CTP             21.345             Dose (mg kg^−1^)   0               19.5   20     20.5   22
  Mortality       0/10               2/10               3/10            4/11   6/10          
  Mortality (%)   0                  20                 30              36.4   60            
  TAT             27.244             Dose (mg kg^−1^)   0               25     27     28     30
  Mortality       0/10               2/9                4/9             5/9    7/8           
  Mortality (%)   0                  22.2               44.4            55.6   87.5          
  R11             16.508             Dose (mg kg^−1^)   0               15.5   16     16.5   17
  Mortality       0/10               1/10               3/10            5/10   7/10          
  Mortality (%)   0                  10                 30              50     70            
  TD              \>140              Dose (mg kg^−1^)   0               80     100    140    --
  Mortality       0/10               0/2                0/8             0/8    --            
  Mortality (%)   0                  0                  0               0      --            

MPPs, membrane‐permeable peptides.

John Wiley & Sons, Ltd

###### 

Mortality and survival periods of mice after injection of GABA‐MPPs

  GABA‐MPPs   Dose (mg kg^−1^)   Mortality    Survival time (min)
  ----------- ------------------ ------------ ---------------------
  GABA‐CTP    ≤10                0/2          Normal
  12.69       0/2                \>180        
  13.05       2/5                2, 4         
  13.41       4/4                1, 2, 1, 1   
  ≥15         2/2                \<1          
  GABA‐TAT    ≤13.41             0/2          Normal
  19.1        2/4                \>180        
  19.2        3/4                2, 3, 4      
  19.3        3/4                1, 2, 1      
  ≥19.5       2/2                1, 1         
  GABA‐TD     50                 0/4          Normal
  100         0/4                Normal       

MPPs, membrane‐permeable peptides; GABA, *γ*‐aminobutyric acid.

John Wiley & Sons, Ltd

We also considered whether there was some residual TFA (\<0.1%) in the synthetic peptides, thus we set a series of TFA control groups in the experiments. It showed that 0.1, 0.5 and 1% of TFA did not manifest any toxicity, whereas the dose rose up to 2%, death appeared in a part of the mice. It seems that residual TFA if any in the synthetic peptides does not influence the results obtained in our experiments.

LD~50~ of TAT‐ChAT {#prp2334-sec-0011}
------------------

The LD~50~ and LD~99~ of TAT‐CHAT in mice came to 338.84 and 480 mg kg^−1^, respectively, (95% of confidence interval was between 275.42 and 416.87 mg kg^−1^). It agrees with the results obtained in many macro‐molecular protein conjugates that we have estimated (Fu et al. [2004](#prp2334-bib-0002){ref-type="ref"}, [2005](#prp2334-bib-0003){ref-type="ref"}, [2006](#prp2334-bib-0004){ref-type="ref"}; Wu et al. [2006](#prp2334-bib-0007){ref-type="ref"}; Qu et al. [2008](#prp2334-bib-0005){ref-type="ref"}; Zhou et al. [2008](#prp2334-bib-0011){ref-type="ref"}; Zhao et al. [2009](#prp2334-bib-0008){ref-type="ref"}, [2011a](#prp2334-bib-0009){ref-type="ref"},[b](#prp2334-bib-0010){ref-type="ref"}). In view of the great difference between the small molecule conjugates and the large molecule conjugates, it seems that the mass ratio of MPP in the conjugate is the key to the question. The larger the mass ratio of MPP in the conjugate, the more toxic the conjugate will be (Table [1](#prp2334-tbl-0001){ref-type="table-wrap"}).

Toxicity of arginine {#prp2334-sec-0012}
--------------------

The mechanism of the poisonous effects caused by TAT and CTP is not yet well understood. However, it is known that L‐arginine stimulates the release of insulin and causes necrotic pancreatitis with specific elevation of amylase in serum and urine. The LD~50~ of arginine in rats come to 3793 mg kg^−1^ (corresponding to 542 mg kg^−1^ in mice) (Saka et al. [2004](#prp2334-bib-0006){ref-type="ref"}). Thus, the higher mass ratio of arginine residues in the conjugate (Table [4](#prp2334-tbl-0004){ref-type="table-wrap"}) might be the best explanation of the toxicity.

###### 

Amino acid sequences of the membrane‐permeable undecapeptides

  Peptides   Sequence      Molecular weight (Dalton)   Content of Arginine (%)   LD~50~ (mg kg^−1^)
  ---------- ------------- --------------------------- ------------------------- --------------------
  TAT        YGRKKRRQRRR   1560                        61                        27
  CTP        YGRRARRRRRR   1558                        81                        21
  R11        RRRRRRRRRRR   1735                        100                       16.5
  TD         ACSSSPSKHCG   1065                        0                         \>140

John Wiley & Sons, Ltd

For a better understanding of the action of arginine, we tested a undecapeptide (R11) completely composed of arginine residues, and another undecapeptide (TD) without any arginine residue. When TD was injected to mice at dose of 140 mg kg^−1^ *via* the tail vein, all the mice well survived even without any side effect appeared, and so did for its GABA conjugate at dose of 100 mg kg^−1^ (Table [1](#prp2334-tbl-0001){ref-type="table-wrap"}). The toxicity of TD is much less than that of TAT and CTP and has a higher survival rate in the in vivo experiments (Table [1](#prp2334-tbl-0001){ref-type="table-wrap"} and [2](#prp2334-tbl-0002){ref-type="table-wrap"}). On the other hand, R11 has a much lower LD~50~ value than that of TAT, CTP and TD. It clearly indicates that transmembrane delivery in vivo *via* the phage displayed peptide TD is an ideal non‐invasive membrane‐permeable carrier.

All these results further support the above‐mentioned explanation of the toxicity of arginine in MPPs. The arginine residue contents in the membrane‐permeating conjugates are correlated with the toxicity to the mice, and the contents of arginine in MPPs calculated based on the relative molecular mass of arginine (157 Dalton) are linear correlation with the toxicity (Fig. [1](#prp2334-fig-0001){ref-type="fig"}).

![The arginine residue contents in the membrane‐permeating conjugates are correlated with the toxicity to the mice.](PRP2-5-e00334-g001){#prp2334-fig-0001}

Discussion and Conclusion {#prp2334-sec-0013}
=========================

In view of the above‐mentioned results, we conclude that the mass percentages of arginine‐rich MPP in their conjugates are critically important for the life security of the mice, and the arginine‐rich MPPs maybe more suitable for using in the macro‐molecular conjugates, but not in the small‐molecular ones.

Disclosures {#prp2334-sec-0015}
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